Tirzepatide + Apitegromab Could Be Exciting, But the Prescription Reality Is Brutal
The new muscle sparing agent is going viral, but there’s a big catch…
The new muscle sparing agent is going viral, but there’s a big catch…
Find obesity and metabolic clinical trials that may be relevant to you, then connect directly with the study team when contact information is available.
Find My Trial2,932 recruiting studies tracked across 418 treatments — sourced from ClinicalTrials.gov.
For much of Foundayo’s development, one of the biggest questions around the drug was whether the liver would become a problem.
On The Pen's flagship podcast — obesity medicine, unfiltered.
Obesity.News
Breaking GLP-1 news, drug development, access updates, and patient-centered analysis, all in one place.
Empowering you to have better conversations with your doctor.
On The Pen covers obesity medicine from the patient's side of the exam table — GLP-1s, access, and the science, reported plainly.
Sponsors & Partners